What is 3Spine?
Founded to revolutionize spinal care, 3Spine is dedicated to the complete lifecycle of low back total joint replacement solutions. Headquartered in Chattanooga, TN, with R&D operations in the Greater Boston area and clinical facilities in the Cayman Islands, the company leverages two decades of research to deliver its MOTUS system. This motion-enabling technology aims to restore natural spinal balance and maintain range of motion, addressing a broad spectrum of lumbar spine indications. The company's integrated approach spans from initial concept and design to clinical validation and patient delivery, positioning it as a unique entity in the healthcare technology landscape.
How much funding has 3Spine raised?
3Spine has raised a total of $51.8M across 4 funding rounds:
Angel/Seed
$1.5M
Series A
$7.3M
Series B
$10M
Series C
$33M
Angel/Seed (2016): $1.5M, investors not publicly disclosed
Series A (2018): $7.3M, investors not publicly disclosed
Series B (2020): $10M, investors not publicly disclosed
Series C (2022): $33M featuring Byron DeFoor
What's next for 3Spine?
The recent major strategic investment signals a pivotal growth phase for 3Spine, likely enabling the company to scale its operations, expand clinical trials, and accelerate the market penetration of its MOTUS system. This infusion of capital, following previous rounds including Series C, Series B, Series A, and initial seed funding, suggests strong investor confidence in 3Spine's innovative approach to spinal joint replacement. The company is poised to further its mission of transforming patient outcomes through advanced, integrated healthcare solutions.
See full 3Spine company page
